Annual Shareholders Equity
$23.40 M
-$19.10 M-44.94%
31 December 2023
Summary:
Pasithea Therapeutics annual stockholders equity is currently $23.40 million, with the most recent change of -$19.10 million (-44.94%) on 31 December 2023. During the last 3 years, it has fallen by -$28.02 million (-54.50%). KTTA annual shareholders equity is now -54.50% below its all-time high of $51.42 million, reached on 31 December 2021.KTTA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$17.81 M
+$1.64 M+10.13%
30 September 2024
Summary:
Pasithea Therapeutics quarterly stockholders equity is currently $17.81 million, with the most recent change of +$1.64 million (+10.13%) on 30 September 2024. Over the past year, it has dropped by -$5.58 million (-23.87%). KTTA quarterly shareholders equity is now -65.39% below its all-time high of $51.47 million, reached on 30 June 2022.KTTA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KTTA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -23.9% |
| 3 y3 years | -54.5% | -65.4% |
| 5 y5 years | - | - |
KTTA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -54.5% | at low | -65.4% | +10.1% |
| 5 y | 5 years | -54.5% | +9592.8% | -65.4% | +3689.3% |
| alltime | all time | -54.5% | +9592.8% | -65.4% | +3689.3% |
Pasithea Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $17.81 M(+10.1%) |
| June 2024 | - | $16.18 M(-18.6%) |
| Mar 2024 | - | $19.88 M(-15.0%) |
| Dec 2023 | $23.40 M(-44.9%) | $23.40 M(-17.5%) |
| Sept 2023 | - | $28.37 M(-20.3%) |
| June 2023 | - | $35.59 M(-9.1%) |
| Mar 2023 | - | $39.14 M(-7.9%) |
| Dec 2022 | $42.50 M | $42.50 M(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $46.79 M(-9.1%) |
| June 2022 | - | $51.47 M(+3.0%) |
| Mar 2022 | - | $49.98 M(-2.8%) |
| Dec 2021 | $51.42 M(>+9900.0%) | $51.42 M(+212.1%) |
| Sept 2021 | - | $16.48 M(+3404.6%) |
| June 2021 | - | $470.10 K(-47.8%) |
| Mar 2021 | - | $900.70 K |
| Dec 2020 | $241.40 K | - |
FAQ
- What is Pasithea Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Pasithea Therapeutics?
- What is Pasithea Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Pasithea Therapeutics?
- What is Pasithea Therapeutics quarterly shareholders equity year-on-year change?
What is Pasithea Therapeutics annual stockholders equity?
The current annual shareholders equity of KTTA is $23.40 M
What is the all time high annual shareholders equity for Pasithea Therapeutics?
Pasithea Therapeutics all-time high annual stockholders equity is $51.42 M
What is Pasithea Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of KTTA is $17.81 M
What is the all time high quarterly shareholders equity for Pasithea Therapeutics?
Pasithea Therapeutics all-time high quarterly stockholders equity is $51.47 M
What is Pasithea Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, KTTA quarterly stockholders equity has changed by -$5.58 M (-23.87%)